Regenerative play Fortuna Fix raises $25M

On Nov. 8, regenerative medicine company Fortuna Fix Inc. (London, U.K.) raised $25 million in an untranched series B led by existing investor Salamander Invest. New investors Amgen Ventures and Macnguyen family office also participated...